resveratrol has been researched along with trinitrobenzenesulfonic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| de la Lastra, CA; Martín, AR; Sánchez-Hidalgo, M; Villegas, I | 1 |
| Abdallah, DM; Ismael, NR | 1 |
| Gong, YY; Heng, D; Li, P; Liang, ML; Lin, L; Wang, Y; Zhu, Y | 1 |
| Ulutas, PA; Ural, M; Yaylali, A; Yildiz, G; Yildiz, Y | 1 |
| Aguiar, P; Antúnez-López, JR; Blanco-Méndez, J; Fernández-Ferreiro, A; Gómez-Lado, N; Lamela-Gómez, I; Lázare-Iglesias, H; Luzardo-Álvarez, A; Otero-Espinar, FJ; Pombo-Pasín, M; Rey-Bretal, D; Ruibal, Á; Seoane-Viaño, I | 1 |
| Alrafas, HR; Busbee, PB; Nagarkatti, M; Nagarkatti, PS | 1 |
6 other study(ies) available for resveratrol and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation; Inflammation; Male; Membrane Proteins; NF-kappa B; Peroxidase; Phytoalexins; Prostaglandin D2; Rats; Rats, Wistar; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Wine | 2006 |
Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cell Adhesion Molecules; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glutathione; Inflammation; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Peroxidase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfasalazine; Trinitrobenzenesulfonic Acid; Vascular Cell Adhesion Molecule-1 | 2011 |
Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts.
Topics: Animals; Cell Line; Colitis; Collagen Type I; Colon; Disease Models, Animal; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Insulin-Like Growth Factor I; Male; MAP Kinase Kinase Kinases; Mice; Mutation; Phosphorylation; Rats, Sprague-Dawley; Receptor, IGF Type 1; Resveratrol; RNA Interference; RNA, Messenger; Signal Transduction; Sirtuin 1; Stilbenes; Transfection; Trinitrobenzenesulfonic Acid | 2014 |
Resveratrol Pretreatment Ameliorates TNBS Colitis in Rats.
Topics: Animals; Antioxidants; Colitis; Female; Inflammatory Bowel Diseases; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Trinitrobenzenesulfonic Acid | 2015 |
Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model.
Topics: Animals; Antioxidants; Colitis; Colon; Melatonin; Positron Emission Tomography Computed Tomography; Rats, Sprague-Dawley; Resveratrol; Trinitrobenzenesulfonic Acid | 2019 |
Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis.
Topics: Animals; Case-Control Studies; Colitis; Colitis, Ulcerative; Down-Regulation; Female; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Mice, Inbred C57BL; MicroRNAs; Resveratrol; T-Lymphocytes, Regulatory; Th17 Cells; Trinitrobenzenesulfonic Acid | 2020 |